Sign in
Active, not recruitingNo phase

Evaluation of the Efficacy of Phospholipid-Bound Omega-3 Versus Omega-3 Alone in Patients With Hypertriglyceridemia: A Randomized Clinical Trial

Key facts

Who runs it
Fundación del Caribe para la Investigación Biomédica
Where
Colombia1 site in 1 countryChoose a country to see its sites
Trial code
Status
Active, not recruiting
People taking part
44 people, planned
Started
17 Dec 2024
Ended
31 Aug 2025
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Intervention Arm: Omega-3 + Phospholipids.
  • Comparator Arm: Omega-3 alone.
Record updated
17 July 2025

Who can take part

Age
18 years to 65 years
Sex
Women and men
Healthy volunteers
Cannot take part
Show the full registry criteria (11)Hide the full registry criteria

Who can take part

  • Patients aged ≥18 to 65 years
  • Triglyceride levels ≥ 150 mg/dL and ≤ 500 mg/dL
  • Signed informed consent

Who cannot take part

  • Use of any lipid-lowering medication
  • Use of substances or prescribed medications that may increase triglyceride levels (e.g., estrogens, atypical antipsychotics, etc.). -
  • Known allergy to the components of the treatment
  • Uncontrolled chronic diseases (e.g., renal failure, liver disease)
  • Any type of cancer
  • Undergoing treatment for HIV
  • Use of omega-3 supplements in the last 3 months
  • Pregnancy or breastfeeding

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Hypertriglyceridemia is a significant risk factor for cardiovascular diseases. Omega-3 fatty acids have been shown to reduce triglyceride levels, and their combination with phospholipids could offer additional benefits in improving lipid profiles and inflammatory markers. This study aims to evaluate the efficacy of combining omega-3 with phospholipids compared to omega-3 alone in patients with hypertriglyceridemia. The objective of the clinical trial is to provide robust evidence on the benefits of this combination in improving lipid profiles and reducing inflammation, which could have a significant impact on clinical practices and future dietary recommendations.

The 2 groups in the trial

  • Group B: Comparator Arm: Omega-3 alone.Existing treatment, for comparison

    Comparator Arm: Omega-3 alone

    Treatment: Comparator Arm: Omega-3 alone.

  • Group A: Intervention Arm: Omega-3 + Phospholipids.Treatment being tested

    Intervention Arm: Omega-3 + Phospholipids.

    Treatment: Intervention Arm: Omega-3 + Phospholipids.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
17 July 2025